Athena Pharmaceutiques Oral Dispersible Tablets

Athena Pharmaceutiques Oral Dispersible Tablets

X

Find the pharmaceutical Marketplace for latest FDF dossiers enquiries of Ranibizumab on PharmaCompass.com

Product

Ranibizumab

Ranibizumab

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 API Suppliers, 1 Listed Suppliers

DEVELOPMENTS

38 Drug(s) in Development

38 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

26 Dossiers, 5 FDA Orange Book, 2 Europe, 2 Canada, 16 Australia, 1 South Africa

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions

7 US Medicaid Prescriptions

MARKET PLACE

2 APIs, 2 DOSSIERS // FDF

DIGITAL CONTENT

1 Data Compilations #Pharmaflow, 90 News

Post an Enquiry

Post an Enquiry

Full View Screen

Full Screen View

Various Finished Dosage Formulations needed in Jordan [ENA11396]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each. 1. Adalimumab (40 mg/ 0.8 ml) Pre-filled Syringes. The required quantity is 40,000 units. 2. Etanercept (25 mg & 50 mg) Pre-filled Syringes. The required quantity is 25,000 units & 250,000 units respectively. 3. Lanreotide Acetate (90 mg & 120 mg) Pre-filled Syringes. The required quantity is 5,000 units & 4,000 units respectively. 4. Filgrastim (300 mcg) Pre-filled Syringes. The required quantity is 150,000 units. 5. Goserelin Acetate (3.6 mg) Implant. The required quantity is 62,000 units. 6. Ranibizumab (10 mg/ ml) Pre-filled Syringes. The required quantity is 12,750 units.

15 Sep 2021

Reply Comment (9)

Reply

Tender// Various Finished Dosage Formulations needed by Sykehusinnkjøp HF in Norway [ENA09241]

Sykehusinnkjøp HF, is looking for Various Finished Dosage Formulations. The suppliers must have a wholesale license or production license for its own preparations in the EEA at the time the tender is submitted. The deadline is 11-Jan-2021. 1. Ranibizumab (10 mg/ ml) Solution for Injection with Cannula. The required quantity is 582 units. 2. Ranibizumab (10 mg/ ml) Solution for Injection. The required quantity is 132 units. 3. Aflibercept (40 mg/ml) Solution for Injection. The required quantity is 29,057 units.

09 Dec 2020

Reply Comment (5)

Reply

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

laboratorium-ofichem-b-v-m-2023-03-20

Access Virtual Booth

Contact Supplier

Begin the journey of your innovative API with Fermion.

Access Virtual Booth

Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search